Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease

被引：22
|
作者：
Kwon, Young-Man [1 ,2 ]
Hwang, Hye Suk [1 ,2 ]
Lee, Jong Seok [1 ,2 ]
Ko, Eun-Ju [1 ,2 ]
Yoo, Si-Eun [1 ,2 ]
Kim, Min-Chul [3 ]
Lee, Yu-Na [1 ,2 ]
Kim, Ki-Hye [1 ,2 ]
Song, Jae-Min [4 ]
Lee, Sujin [5 ,6 ]
Moore, Martin L. [5 ,6 ]
Kang, Sang-Moo [1 ,2 ]
机构：
[1] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA
[2] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA
[3] Anim & Plant Quarantine Agcy, Anyang, Gyeonggi Do, South Korea
[4] Sungshin Womens Univ, Dept Global Med Sci, Seoul, South Korea
[5] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA
[6] Childrens Healthcare Atlanta, Atlanta, GA USA
来源：
ANTIVIRAL RESEARCH | 2014年 / 104卷
关键词：
Maternal antibodies; FI-RSV; Passive immunization; Vaccine enhanced disease; PULMONARY INFLAMMATORY RESPONSE; T-CELL RESPONSES; COTTON RATS; RSV VACCINE; G PROTEIN; INFECTION; MICE; PALIVIZUMAB; EOSINOPHILIA; CHALLENGE;
D O I：
10.1016/j.antiviral.2014.01.008
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Maternal immunization of mice with formalin inactivated respiratory syncytial virus (FI-RSV) resulted in the passive transfer of RSV antibodies but not cellular components to the offspring. The offspring born to FI-RSV immunized mothers showed serum RSV neutralizing activity, effectively controlled lung viral loads without vaccine-enhanced disease, did not induce pulmonary eosinophilia, and cytokine producing cells after live RSV infection. Therefore, this study provides evidence that maternal immunization provides an in vivo model in investigating the roles of antibodies independent of cellular components. (c) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码：1 / 6
页数：6
相关论文
共 50 条
  • [41] OUTCOME OF RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION AFTER PRIOR SYSTEMIC IMMUNIZATION WITH INACTIVATED RSV VACCINE
    DHAR, R
    WONG, DT
    HOVEY, KA
    OGRA, PL
    PEDIATRIC RESEARCH, 1985, 19 (04) : A291 - A291
  • [42] Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease
    Prince, GA
    Denamur, F
    Deschamps, M
    Garçon, N
    Prieels, JP
    Slaoui, M
    Thiriart, C
    Porter, DD
    VACCINE, 2001, 19 (15-16) : 2048 - 2054
  • [43] RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE
    KIM, HW
    CANCHOLA, JG
    BRANDT, CD
    PYLES, G
    CHANOCK, RM
    JENSEN, K
    PARROTT, RH
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) : 422 - +
  • [44] A HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) PRIMATE MODEL OF ENHANCED PULMONARY PATHOLOGY INDUCED WITH A FORMALIN-INACTIVATED RSV VACCINE BUT NOT A RECOMBINANT FG SUBUNIT VACCINE
    KAKUK, TJ
    SOIKE, K
    BRIDEAU, RJ
    ZAYA, RM
    COLE, SL
    ZHANG, JY
    ROBERTS, ED
    WELLS, PA
    WATHEN, MW
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03): : 553 - 561
  • [45] A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease
    Li, Chaofan
    Zhou, Xian
    Zhong, Yiwei
    Li, Changgui
    Dong, Aihua
    He, Zhonghuai
    Zhang, Shuren
    Wang, Bin
    JOURNAL OF IMMUNOLOGY, 2016, 196 (04): : 1721 - 1731
  • [46] Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge
    Welliver, Robert C.
    Papin, James F.
    Preno, Alisha
    Ivanov, Vadim
    Tian, Jing-Hui
    Lu, Hanxin
    Guebre-Xabier, Mimi
    Flyer, David
    Massare, Michael J.
    Glenn, Greg
    Ellingsworth, Larry
    Smith, Gale
    VACCINE, 2020, 38 (05) : 1258 - 1270
  • [47] ENHANCED PULMONARY PATHOLOGY ASSOCIATED WITH THE USE OF FORMALIN-INACTIVATED RESPIRATORY SYNCYTIAL VIRUS-VACCINE IN COTTON RATS IS NOT A UNIQUE VIRAL PHENOMENON
    PIEDRA, PA
    WYDE, PR
    CASTLEMAN, WL
    AMBROSE, MW
    JEWELL, AM
    SPEELMAN, DJ
    HILDRETH, SW
    VACCINE, 1993, 11 (14) : 1415 - 1423
  • [48] Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate
    Plotnicky, H
    Siegrist, CA
    Aubry, JP
    Bonnefroy, JY
    Corvaïa, N
    Nguyen, TN
    Power, UF
    VACCINE, 2003, 21 (19-20) : 2651 - 2660
  • [49] Interleukin-27 Inhibits Vaccine-Enhanced Pulmonary Disease following Respiratory Syncytial Virus Infection by Regulating Cellular Memory Responses
    Zeng, Ruihong
    Zhang, Huixian
    Hai, Yan
    Cui, Yuxiu
    Wei, Lin
    Li, Na
    Liu, Jianxun
    Li, Caixia
    Liu, Ying
    JOURNAL OF VIROLOGY, 2012, 86 (08) : 4505 - 4517
  • [50] Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation
    Garg, R.
    Latimer, L.
    Simko, E.
    Gerdts, V.
    Potter, A.
    van Drunen Littel-van den Hurk, S.
    JOURNAL OF GENERAL VIROLOGY, 2014, 95 : 301 - 306
12345